NCT00825019 Efficacy and Safety of One Single Dose of SR58611 Compared to Placebo and Paroxetine Status COMPLETED Phase PHASE3
NCT00822744 An Eight-week Study of SSR411298 as Treatment for Major Depressive Disorder in Elderly Patients Status COMPLETED Phase PHASE2
NCT00821834 Safety Evaluation of Clopidogrel Sulfate in Patients With Stable Angina/Old Myocardial Infarction to Whom Percutaneous Coronary Intervention is Being Planned Status COMPLETED Phase PHASE3
NCT00819754 A Phase I/II Study of IXO With Bevacizumab in Patients With Metastatic Colorectal Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT00819728 Trial of Weekly Taxotere and Irinotecan (CPT-11) in Patients With Advanced Non-small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00819013 Safety Study of Recombinant M2e Influenza-A Vaccine in Healthy Adults Status COMPLETED Phase PHASE1
NCT00816543 Docetaxel + Oxaliplatin + S-1 in Potentially Operable Gastric or Gastroesophageal Adenocarcinoma Status COMPLETED Phase PHASE2
NCT00816452 Awareness to Osteopenia's Treatment by Bisphosphonate in Male Suffering From Prostate Cancer Status COMPLETED Phase N/A
NCT00814268 COMbination of Clopidogrel and Aspirin for Prevention of Early REcurrence in Acute Atherothrombotic Stroke Status COMPLETED Phase PHASE4
NCT00813956 A Phase 2 Study of Standard Chemotherapy Plus BSI-201 (a PARP Inhibitor) in the Neoadjuvant Treatment of Triple Negative Breast Cancer Status COMPLETED Phase PHASE2
NCT00811902 Efficacy, Safety, and Tolerability of Nerispirdine in Patients With Multiple Sclerosis Status COMPLETED Phase PHASE2
NCT00811447 Taxotere New Indication - Gastric Cancer Treatment Registration Trial Status COMPLETED Phase PHASE3
NCT00811395 Long Term Safety of Teriflunomide When Added to Interferon-Beta or Glatiramer Acetate in Patients With Multiple Sclerosis Status COMPLETED Phase PHASE2
NCT00811031 Preoperative Docetaxel for Localized Progressive Castration-resistant Prostate Cancer (CRPC) Status WITHDRAWN Phase PHASE2
NCT00810121 Study of Non Inferiority Bi-Profenid® 200mg Versus Bi-Profenid® 300mg Among Patients Presenting of the Post-traumatic or Rheumatologic Acute Affections of the Locomotor Apparatus (BIPROPAIN) Status COMPLETED Phase PHASE3
NCT00807170 Investigate the Maximum Tolerated Dose of Vandetanib and Concurrent Whole Brain Radiotherapy (WBRT) in Patients With Non-small Cell Lung Cancer (NSCLC) and Brain Metastases Status TERMINATED Phase PHASE1
NCT00805350 Efficacy and Safety of Eplivanserin 5mg/Day in Insomnia Characterized by Sleep Maintenance Difficulties Status COMPLETED Phase PHASE3
NCT00803049 Long Term Safety and Efficacy Study of Teriflunomide 7 mg or 14 mg in Patients With Relapsing-Remitting Multiple Sclerosis Status COMPLETED Phase PHASE3
NCT00801801 Study of Low Dose Chemotherapy Plus Sorafenib as Initial Therapy for Patients With Advanced Non-Squamous Cell NSCLC Status TERMINATED Phase PHASE2